Health Product InfoWatch – October 2021

Monthly recap of health product safety information. The following is a list of health product advisories, type I recalls and summaries of completed safety reviews published in September 2021 by Health Canada.

Data and Resources

Additional Info

Field Value
Last Updated April 17, 2026, 17:37 (UTC)
Created April 17, 2026, 17:37 (UTC)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2021-10-28 00:00:00
open_canada_keywords {"fr": ["InfoVigilance", "produits", "santé", "octobre", "2021", "COVID", "pandémie", "COVID-19", "Coronavirus", "Comorbidité", "surmortalité", "Agents", "contraste", "base", "gadolinium", "CellCept", "(mofétilmycophénolate)", "Glucagon", "Losartan", "Lumakras", "(sotorasib)", "Mirvala 28", "Pemazyre (pemigatinib)", "Truseltiq", "(infigratinib)", "Zepzelca", "(lurbinectédine)", "Zyloprim", "(allopurinol)"], "en": ["pandemic", "COVID-19", "Coronavirus", "COVID", "Health", "Product", "InfoWatch", "October", "2021", "Pharmaceuticals", "biologics", "CellCept", "(mycophenolate mofetil)", "Gadolinium-based", "contrast agents", "Glucagon", "Losartan", "Lumakras (sotorasib)", "Mirvala 28", "Pemazyre (pemigatinib)", "Truseltiq (infigratinib)", "Zepzelca (lurbinectedin)", "Zyloprim (allopurinol)", "Coronavirus disease", "(COVID-19)", "Monthly recap", "New information", "Vaccine", "safety", "biannual", "summary", "January 1", "2020", "June 30", "2020", "Product monograph", "update", "CellCept", "(mycophenolate mofetil)", "Zyloprim", "(allopurinol)", "Lumakras", "(sotorasib)", "Pemazyre", "(pemigatinib)", "Truseltiq", "(infigratinib)", "Notice", "market", "authorization", "conditions", "Zepzelca", "(lurbinectedin)", "Scope", "Reporting", "Adverse", "Reactions"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr InfoVigilance sur les produits de santé – octobre 2021
update_frequency P1M